• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

化脓性汗腺炎患者瘙痒和疼痛的临床特征。

Clinical Characteristics of Pruritus and Pain in Patients with Hidradenitis Suppurativa.

机构信息

Department of Dermatology, Venereology and Allergology, Medical University, Chałubińskiego 1, PL-50-368 Wrocław, Poland.

出版信息

Acta Derm Venereol. 2018 Feb 7;98(2):191-194. doi: 10.2340/00015555-2815.

DOI:10.2340/00015555-2815
PMID:28971209
Abstract

A growing body of research has indicated that pruritus is an important feature of hidradenitis suppurativa (HS). This study evaluated pruritus and pain among 103 patients with HS. Pruritus and pain intensity were assessed with a visual analogue scale, numerical rating scale and 4-item Itch Questionnaire. Dermatology Life Quality Index (DLQI) was implemented to assess quality of life (QoL) issues. Various clinical features and factors influencing pruritus were also examined. Pruritus and pain during the last week were reported among 41.7% and 77.5% of patients, respectively. The presence of pruritus did not have an impact on DLQI, nor did it show interaction with the pain in this regard. The presence of pain was a crucial contributor, even more relevant than disease severity. None-theless, intensity of pruritus correlated positively with DLQI. The most troublesome symptom of HS was pain, followed by exudation, pruritus, appearance and smell, consecutively. Pruritus of mild-to-moderate intensity is a common HS-associated symptom that adversely affects patients' QoL.

摘要

越来越多的研究表明瘙痒是化脓性汗腺炎(HS)的一个重要特征。本研究评估了 103 例 HS 患者的瘙痒和疼痛情况。瘙痒和疼痛强度采用视觉模拟评分法、数字评分法和 4 项瘙痒问卷进行评估。皮肤病生活质量指数(DLQI)用于评估生活质量(QoL)问题。还检查了各种临床特征和影响瘙痒的因素。分别有 41.7%和 77.5%的患者报告了过去一周的瘙痒和疼痛。瘙痒的存在对 DLQI 没有影响,在这方面也没有与疼痛相互作用。疼痛的存在是一个重要的因素,甚至比疾病严重程度更相关。然而,瘙痒的强度与 DLQI 呈正相关。HS 最麻烦的症状是疼痛,其次是渗出、瘙痒、外观和气味,依次排列。轻度至中度强度的瘙痒是化脓性汗腺炎的常见相关症状,会对患者的生活质量产生不利影响。

相似文献

1
Clinical Characteristics of Pruritus and Pain in Patients with Hidradenitis Suppurativa.化脓性汗腺炎患者瘙痒和疼痛的临床特征。
Acta Derm Venereol. 2018 Feb 7;98(2):191-194. doi: 10.2340/00015555-2815.
2
Influence of Itch and Pain on Sleep Quality in Patients with Hidradenitis Suppurativa.化脓性汗腺炎患者瘙痒和疼痛对睡眠质量的影响。
Acta Derm Venereol. 2018 Aug 29;98(8):757-761. doi: 10.2340/00015555-2967.
3
The Burden of Hidradenitis Suppurativa Signs and Symptoms in Quality of Life: Systematic Review and Meta-Analysis.化脓性汗腺炎体征和症状对生活质量的影响负担:系统评价和荟萃分析。
Int J Environ Res Public Health. 2021 Jun 22;18(13):6709. doi: 10.3390/ijerph18136709.
4
Pruritus and Malodour in Patients with Hidradenitis Suppurativa: Impact on Quality of Life and Clinical Features Associated with Symptom Severity.化脓性汗腺炎患者的瘙痒和异味:对生活质量的影响及与症状严重程度相关的临床特征。
Dermatology. 2020;236(1):59-65. doi: 10.1159/000502139. Epub 2019 Aug 29.
5
Assessing Pruritus in Hidradenitis Suppurativa: A Cross-Sectional Study.评估化脓性汗腺炎的瘙痒:一项横断面研究。
Am J Clin Dermatol. 2017 Oct;18(5):687-695. doi: 10.1007/s40257-017-0280-2.
6
Disutility in Patients with Hidradenitis Suppurativa: A Cross-sectional Study Using EuroQoL-5D.化脓性汗腺炎患者的负效用:一项使用欧洲五维健康量表的横断面研究。
Acta Derm Venereol. 2016 Feb;96(2):222-6. doi: 10.2340/00015555-2129.
7
AISI: A New Disease Severity Assessment Tool for Hidradenitis Suppurativa.AISI:一种用于化脓性汗腺炎的新疾病严重程度评估工具。
Wounds. 2015 Oct;27(10):258-64.
8
The Influence of Pain on Reduced Quality of Life in Patients with Hidradenitis Suppurativa: A Single-Center Retrospective Study.疼痛对化脓性汗腺炎患者生活质量降低的影响:一项单中心回顾性研究。
Dermatology. 2023;239(6):1007-1012. doi: 10.1159/000533740. Epub 2023 Sep 16.
9
Assessing the psychological burden of patients with hidradenitis suppurativa.评估化脓性汗腺炎患者的心理负担。
Eur J Dermatol. 2019 Jun 1;29(3):294-301. doi: 10.1684/ejd.2019.3552.
10
Pain and pruritus in cutaneous lupus: their association with dermatologic quality of life and disease activity.皮肤狼疮的疼痛和瘙痒:与皮肤病生活质量和疾病活动的关联。
Clin Exp Rheumatol. 2013 Nov-Dec;31(6):940-2. Epub 2013 Aug 2.

引用本文的文献

1
Assessing Long-Term Pain Reduction with Secukinumab in Moderate to Severe Hidradenitis Suppurativa: A Post Hoc Analysis of the SUNSHINE and SUNRISE Phase 3 Trials.司库奇尤单抗治疗中度至重度化脓性汗腺炎的长期疼痛缓解评估:SUNSHINE和SUNRISE 3期试验的事后分析
Dermatol Ther (Heidelb). 2025 May 15. doi: 10.1007/s13555-025-01426-x.
2
Correlation of Psychosomatic Factors and Personality Traits with The Severity of Hidradenitis Suppurativa.心理因素和人格特质与化脓性汗腺炎严重程度的相关性
Dermatol Pract Concept. 2025 Jan 30;15(1):4566. doi: 10.5826/dpc.1404a4566.
3
Development and Validation of a Disease-specific Outcomes Tool for the Assessment of Patient Benefits of Treatment for Hidradenitis Suppurativa: the PBI-HS.
化脓性汗腺炎治疗患者获益评估的疾病特异性结局工具的开发与验证:化脓性汗腺炎患者获益指数(PBI-HS)
Acta Derm Venereol. 2025 Mar 6;105:adv41298. doi: 10.2340/actadv.v105.41298.
4
Hidradenitis Suppurativa Tunnels: Unveiling a Unique Disease Entity.化脓性汗腺炎窦道:揭示一种独特的疾病实体。
JID Innov. 2025 Jan 21;5(3):100350. doi: 10.1016/j.xjidi.2025.100350. eCollection 2025 May.
5
A marker of systemic inflammation in hidradenitis suppurativa patients without cardiovascular disease: aortic arch calcification.化脓性汗腺炎患者无心血管疾病的全身炎症标志物:主动脉弓钙化。
Arch Dermatol Res. 2024 Oct 26;316(10):709. doi: 10.1007/s00403-024-03461-8.
6
Hidradenitis Suppurativa in Elderly Patients: Clinical and Therapeutical Outcomes-A Review of the Literature.老年化脓性汗腺炎患者:临床和治疗结果——文献综述。
Medicina (Kaunas). 2024 Sep 6;60(9):1465. doi: 10.3390/medicina60091465.
7
Essentials of hidradenitis suppurativa: a comprehensive review of diagnostic and treatment perspectives.化脓性汗腺炎要点:诊断与治疗观点的全面综述
Ann Med Surg (Lond). 2024 Jul 1;86(9):5304-5313. doi: 10.1097/MS9.0000000000002345. eCollection 2024 Sep.
8
Guidelines How to Integrate Surgery and Targeted Therapy with Biologics for the Treatment of Hidradenitis Suppurativa: Delphi Consensus Statements from an Italian Expert Panel.如何将手术与生物制剂靶向治疗相结合治疗化脓性汗腺炎的指南:来自意大利专家小组的德尔菲共识声明
Dermatology. 2024;240(5-6):885-896. doi: 10.1159/000539264. Epub 2024 Jul 18.
9
Comorbidities, Clinical Presentation, Subtypes, and Treatment of HS Patients in Lithuania.立陶宛HS患者的合并症、临床表现、亚型及治疗
J Clin Med. 2024 Jul 3;13(13):3900. doi: 10.3390/jcm13133900.
10
Burden of Hidradenitis Suppurativa: A Systematic Literature Review of Patient Reported Outcomes.化脓性汗腺炎的负担:患者报告结局的系统文献综述
Dermatol Ther (Heidelb). 2024 Jan;14(1):83-98. doi: 10.1007/s13555-023-01085-w. Epub 2024 Jan 6.